Is treatment with trimetazidine beneficial in patients with chronic heart failure? - Wikidata - awgldk - TriplyDB

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

http://www.wikidata.org/entity/Q33567682

about

Review of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studies Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis Trimetazidine improves exercise tolerance in patients with ischemic heart disease : A meta-analysis.Effects of exercise-based cardiac rehabilitation in patients after percutaneous coronary intervention: A meta-analysis of randomized controlled trials.Mitochondrial dysfunction and its impact on diabetic heart.Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure.Effects of bisoprolol in combination with trimetazidine on the treatment of heart failure and concomitant chronic obstructive pulmonary disease Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease.Effectiveness and safety of anti-ischemic trimetazidine in patients with stable angina pectoris and Type 2 diabetes.Beneficial effects of trimetazidine on expression of serotonin and serotonin transporter in rats with myocardial infarction and depression.Metabolic Modulation of Cardiac Metabolism in Heart Failure

P2860

Q26746907-D600242D-2FCE-4ACF-B67E-699A0E1F5DAA Q26787236-C8E9B0FC-62A6-47FD-96E0-E4209CB22484 Q35868838-9E80D592-1896-4470-A7C8-A896A34261EE Q37708122-25D15DF7-2EE2-450A-9ECD-B79F7C2A5E64 Q38946122-723979D8-8E79-4F74-8E8B-96D67EA5A35B Q41297700-10DC1662-3643-47FD-854A-49BD13A6752A Q42371047-AD1B48F0-DB1B-4CDE-9AC1-321691E16907 Q49247394-6A098447-567A-45B6-A4DA-1EB01A4D688F Q49930063-C48B5276-9D91-4F19-9C3D-68A163DA4220 Q55172019-B9324F4D-5D06-4A7C-AA50-AF593A72F334 Q58804689-E82F39DA-2271-412C-AC0C-5E5D9A0FD357

P2860

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

http://www.wikidata.org/entity/Q33567682

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

@ast

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

@en

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

@nl

type

label

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

@ast

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

@en

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

@nl

prefLabel

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

@ast

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

@en

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

@nl

P1433

Q33567682-14D7EAF6-E127-4DDA-BDC5-BA817E268805

P1476

Q33567682-A7067E35-9B80-4EF5-B56E-4D49D91FA145

P2093

Q33567682-45A5AAC7-5EEE-4921-93D8-D4FEBE4D8619

Q33567682-DC1CDA40-901B-4EC4-9AAC-353CC5F5D3C3

P275

Q33567682-57FD5ABC-14D1-4FF6-B0C3-23892BB2DEDD

P2860

Q33567682-0096EE83-D413-4A07-BD22-DF6FDDC5C6C1

Q33567682-0728ECAC-5FBD-4190-A0C4-258DCCCFEBAF

Q33567682-11EA66F7-9A23-4A85-B37B-861DE24B8F07

Q33567682-1475A6F4-D0D4-462D-9BD8-A0BDC618D96D

Q33567682-27632C26-6BE0-47EC-8E4A-52A9CD908742

Q33567682-2CBCE2C1-418E-42FB-9330-8E6CB8ADA898

Q33567682-30E7985E-D76F-477A-8514-7F7DF9FB078E

Q33567682-3333DEB7-73C7-45E4-9B0B-BD25F5E87AD4

Q33567682-4A41734E-1CB6-4E27-AE29-3C5B01F951A0

Q33567682-617A73C3-8FC8-4B01-8202-A04F258A59B0

P304

Q33567682-B67AD4D7-E5DD-4B14-A162-942DF26CA9ED

P31

Q33567682-03F4EBB7-4148-4E85-97B0-12BF74881768

Q33567682-3947b69b-d6f3-40e2-bcb8-19658b1aad22

Q33567682-4E07C6B3-C9D3-4881-ACC6-0C28F8651038

P356

Q33567682-7C95661A-E5BD-45D7-80C2-67A8FAB2A252

P407

Q33567682-0799FDE6-D988-40F6-8581-1312D87E1BD4

P433

Q33567682-49F4DBC3-4EBE-451B-BB6B-5260B4E32650

P478

Q33567682-785E80D5-157B-42B3-83AF-57A8487F598E

P5008

Q33567682-A273A5F6-22EB-4EE7-B7F2-D4C526E172F7

P577

Q33567682-5CC11646-2D00-45C7-99EC-756CBF224B22

P5875

Q33567682-4A18DBBB-9BCD-48A5-9A56-77669A1A88EF

P698

Q33567682-8619ECAF-AED4-4F57-B1B8-7AC7FCC7DA43

P921

Q33567682-2C87155F-541F-4A89-80B4-B61853BE7019

Q33567682-37EF59A4-1035-4F4F-968D-4322B3E98A31

P932

Q33567682-FE28053C-CF56-4181-92D2-59EA1E32BB22

P356

JOURNAL.PONE.0094660

P1433

P1476

Is treatment with trimetazidine beneficial in patients with chronic heart failure?

@en

P2093

Jianchang Chen

http://www.w3.org/2001/XMLSchema#string

Xiang Zhou

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy.

Trimetazidine protects against smoking-induced left ventricular remodeling via attenuating oxidative stress, apoptosis, and inflammation

A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.

Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy.

Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure.

Trimetazidine: a meta-analysis of randomised controlled trials in heart failure.

P304

e94660

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0094660

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2014-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262074491

http://www.w3.org/2001/XMLSchema#string

P698

24797235

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

P932

4010408

http://www.w3.org/2001/XMLSchema#string